CA2402846A1 - Traitement de l'acne rosacee - Google Patents

Traitement de l'acne rosacee Download PDF

Info

Publication number
CA2402846A1
CA2402846A1 CA002402846A CA2402846A CA2402846A1 CA 2402846 A1 CA2402846 A1 CA 2402846A1 CA 002402846 A CA002402846 A CA 002402846A CA 2402846 A CA2402846 A CA 2402846A CA 2402846 A1 CA2402846 A1 CA 2402846A1
Authority
CA
Canada
Prior art keywords
phe
tyr
cyclo
asp
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002402846A
Other languages
English (en)
Inventor
Michael T. Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seatek Marine Biotechnology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002301336A external-priority patent/CA2301336A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002402846A priority Critical patent/CA2402846A1/fr
Publication of CA2402846A1 publication Critical patent/CA2402846A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des antibiotiques peptidiques cycliques, comprenant des loloatines efficaces pour traiter l'acné rosacée, notamment lorsqu'on les administre avec un antibiotique, tel que le métronidazole, efficace contre les bactéries anaérobies.
CA002402846A 2000-03-17 2001-03-19 Traitement de l'acne rosacee Abandoned CA2402846A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002402846A CA2402846A1 (fr) 2000-03-17 2001-03-19 Traitement de l'acne rosacee

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA2,301,336 2000-03-17
CA002301336A CA2301336A1 (fr) 2000-03-17 2000-03-17 Traitement topique contre la rosacee
CA002402846A CA2402846A1 (fr) 2000-03-17 2001-03-19 Traitement de l'acne rosacee
PCT/CA2001/000358 WO2001068675A2 (fr) 2000-03-17 2001-03-19 Traitement de l'acne rosacee

Publications (1)

Publication Number Publication Date
CA2402846A1 true CA2402846A1 (fr) 2001-09-20

Family

ID=25681636

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002402846A Abandoned CA2402846A1 (fr) 2000-03-17 2001-03-19 Traitement de l'acne rosacee

Country Status (1)

Country Link
CA (1) CA2402846A1 (fr)

Similar Documents

Publication Publication Date Title
JP4192114B2 (ja) 環式付着阻害剤
AU624278B2 (en) Method of inhibiting synaptic norepinerphrine uptake and synapitc serotionin uptake in a depressed patient
US6204279B1 (en) Peptidomimetic efflux pump inhibitors
CN105308065A (zh) 多粘菌素衍生物及其在与不同抗生素的组合疗法中的用途
AU6268799A (en) Methods for administration of antibiotics
EP1758920A1 (fr) Inhibiteurs de pompe a ecoulement bacterien et procedes pour traiter des infections bacteriennes
WO2011005355A1 (fr) Combinaisons comprenant un inhibiteur de lpxc et un antibiotique à utiliser dans le traitement d'infections induites par des bactéries à gram négatif
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
GB2259647A (en) Ranitidine salt compositions
AU672384B2 (en) Pharmaceutical bacteriocin compositions
AU2007291517A1 (en) Pharmaceutical compositions for the treatment of fungal infections
JP2020533417A (ja) 抗菌組成物
WO2022028243A1 (fr) Utilisation d'acides aminés composés dans la préparation de médicaments améliorant la sensibilité de bactéries à des antibiotiques
US7153826B2 (en) Treatment of rosacea
CA2516458C (fr) Utilisation de composes de kahalalide pour la fabrication d'un medicament pour le traitement de psoriasis
CA2402846A1 (fr) Traitement de l'acne rosacee
EP2948129A1 (fr) Composés thérapeutiques
AU3810893A (en) Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
JP2016503043A (ja) 乾癬を処置するためのピドチモドの使用
JP2003246726A (ja) 抗菌組成物
CA2861199C (fr) Traitement d'infections microbiennes avec du delmopinol et du cetylpyridinium
US4727062A (en) 3-Halovinylglycine antibacterial agents
US4806680A (en) 3-halovinylglycine antibacterial agents
JP7253128B2 (ja) デプシペプチド系抗生物質を含有する外用組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead